June 2026 News
Two new high-throughput targeted sequencing (NGS) panels for inherited cardiac diseases and genetic cardiac rhythm disorders are now reimbursed in France.
Supported by recommendations from the French National Authority for Health (HAS), these new panels expand access to genetic diagnosis for patients with inherited cardiomyopathies, including hypertrophic (HCM), dilated (DCM), arrhythmogenic (ARVC), restrictive (RCM) and left ventricular non-compaction forms (LVNC), helping to support earlier diagnosis and optimized patient management.